Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$23.64 - $30.27 $2,553 - $3,269
-108 Reduced 1.01%
10,591 $306,000
Q3 2023

Nov 15, 2023

BUY
$26.74 - $40.81 $67,866 - $103,575
2,538 Added 31.1%
10,699 $286,000
Q2 2023

Aug 11, 2023

SELL
$28.52 - $40.7 $15,600 - $22,262
-547 Reduced 6.28%
8,161 $302,000
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $7,876 - $9,720
-268 Reduced 3.08%
8,440 $263,000
Q4 2022

Aug 11, 2023

BUY
$29.23 - $40.28 $1,753 - $2,416
60 Added 0.69%
8,708 $259,000
Q4 2022

Feb 13, 2023

BUY
$29.23 - $40.28 $1,753 - $2,416
60 Added 0.69%
8,708 $259,000
Q3 2022

Aug 11, 2023

SELL
$37.92 - $63.74 $5,498 - $9,242
-145 Reduced 1.65%
8,648 $329,000
Q3 2022

Nov 03, 2022

SELL
$37.92 - $63.74 $5,498 - $9,242
-145 Reduced 1.65%
8,648 $330,000
Q2 2022

Aug 11, 2023

BUY
$47.98 - $62.75 $4,366 - $5,710
91 Added 1.05%
8,793 $479,000
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $4,366 - $5,710
91 Added 1.05%
8,793 $479,000
Q1 2022

Aug 11, 2023

BUY
$49.85 - $96.11 $13,060 - $25,180
262 Added 3.1%
8,702 $543,000
Q1 2022

May 20, 2022

SELL
$49.85 - $96.11 $94,266 - $181,744
-1,891 Reduced 17.85%
8,702 $543,000
Q4 2021

Feb 16, 2022

BUY
$77.3 - $105.0 $773 - $1,050
10 Added 0.09%
10,593 $1.07 Million
Q3 2021

Nov 12, 2021

SELL
$74.87 - $110.87 $59,970 - $88,806
-801 Reduced 7.04%
10,583 $952,000
Q2 2021

Aug 12, 2021

BUY
$66.8 - $100.45 $248,095 - $373,071
3,714 Added 48.42%
11,384 $1.05 Million
Q1 2021

May 03, 2021

SELL
$59.3 - $183.85 $25,795 - $79,974
-435 Reduced 5.37%
7,670 $741,000
Q4 2020

Feb 12, 2021

BUY
$31.01 - $52.1 $64,686 - $108,680
2,086 Added 34.66%
8,105 $422,000
Q3 2020

Nov 09, 2020

BUY
$15.89 - $50.51 $95,641 - $304,019
6,019 New
6,019 $241,000
Q3 2018

Nov 14, 2018

SELL
$3.29 - $5.12 $592 - $921
-180 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$4.57 - $6.39 $822 - $1,150
180
180 $1,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.